Download presentation
Presentation is loading. Please wait.
Published byRobert Wallace Modified over 11 years ago
1
Lucia Torracca HEART FAILURE & Co. Milano 9 - 10 aprile 2010
Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010 Lucia Torracca
2
Il bypass aorto-coronarico: più rischioso e meno efficace?
L. Torracca Direttore U.O. Cardiochirurgia A.O.U. Ospedali Riuniti “Umberto I- G. M. Lancisi- G. Salesi” Presidio Monospecialistico “G. M. Lancisi” Ancona
3
Preoperative risk profile (women versus men)
Older Diabetes/Obesity/Hypertension Smaller body surface area Lower hematocrit Congestive heart failure/NYHA class IV IV heparin/nitroglycerin Urgent/emergent operation Higher STS estimated mortality Single center consecutive 1743 pts Aldea Ann Thorac Surg 1999
4
Gender profiling in CABG
15,597 pts Cleveland Clinic Koch JTCVS 2003;126:2044
5
Operative mortality 344,913 pts from STS database 5
6
Operative mortality 6
7
Operative mortality 7
8
Operative mortality 8
9
Operative mortality 9
10
Operative risk factors
Aldea Ann Thorac Surg 1999 10
11
Operative risk factors Internal mammary artery use
FEMALE vs MALE 64% 78% O’Connor 1993 65% 76% Edwards 1998 67% 80% Humphries 2007 83% 89% Bukkapatnam 2010 11
12
Outcome 1113 pts followed for 6-8 weeks after CABG 12
13
QOL before and after CABG
Peric V. ICVTS 2010;10:232
14
QOL before and after CABG
Peric V. ICVTS 2010;10:232
15
Quality of life 15
17
Women may benefit of a more aggressive rehabilitation program
18
- 2 groups of patients 261 women and 261 men “computer-matched”
- All pts bilateral IMA graft - Hospital mortality 3,4% vs 3,8% (women vs men)
22
Gender and off-pump 22
23
Gender and off-pump 23
24
Female and leg wound complications
Paletta Ann Thorac Surg 2000;70:492 24
25
Endoscopic vein harvesting
Yun JCTS 2005;129:496
26
Increase the use of “at least” one or “better” two mammary arteries
Optimal management of blood glucose level ( mg/dl) Intraop management of anemia (nadir Ht>22 during CPB): reduce pump prime, ultrafiltration 26
27
Use of off-pump surgery ? Optimization of thyroxine treatment
Hormone replacement therapy??? 27
28
Thanks for the attention!
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.